Your browser doesn't support javascript.
loading
A rare splice donor mutation in the haptoglobin gene associates with blood lipid levels and coronary artery disease.
Bjornsson, Eythor; Helgason, Hannes; Halldorsson, Gisli; Helgadottir, Anna; Gylfason, Arnaldur; Kehr, Birte; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Oddsson, Asmundur; Thorleifsson, Gudmar; Magnusson, Olafur Th; Gretarsdottir, Solveig; Zink, Florian; Kristjansson, Ragnar P; Asgeirsdottir, Margret; Swinkels, Dorine W; Kiemeney, Lambertus A; Eyjolfsson, Gudmundur I; Sigurdardottir, Olof; Masson, Gisli; Olafsson, Isleifur; Thorgeirsson, Gudmundur; Holm, Hilma; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F; Sulem, Patrick; Stefansson, Kari.
Afiliação
  • Bjornsson E; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Helgason H; Faculty of Medicine.
  • Halldorsson G; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Helgadottir A; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
  • Gylfason A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Kehr B; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Jonasdottir A; Faculty of Medicine.
  • Jonasdottir A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sigurdsson A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Oddsson A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Thorleifsson G; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Magnusson OT; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Gretarsdottir S; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Zink F; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Kristjansson RP; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Asgeirsdottir M; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Swinkels DW; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Kiemeney LA; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Eyjolfsson GI; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sigurdardottir O; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Department of Laboratory Medicine, Nijmegen, The Netherlands.
  • Masson G; Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Olafsson I; The Laboratory in Mjodd, Reykjavik, Iceland.
  • Thorgeirsson G; Department of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
  • Holm H; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Thorsteinsdottir U; Department of Clinical Biochemistry.
  • Gudbjartsson DF; Faculty of Medicine.
  • Sulem P; Division of Cardiology, Department of Internal Medicine, Landspitali, National University Hospital of Iceland, Reykjavik, Iceland.
  • Stefansson K; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Hum Mol Genet ; 26(12): 2364-2376, 2017 06 15.
Article em En | MEDLINE | ID: mdl-28398513
ABSTRACT
Common sequence variants at the haptoglobin gene (HP) have been associated with blood lipid levels. Through whole-genome sequencing of 8,453 Icelanders, we discovered a splice donor founder mutation in HP (NM_001126102.1c.190 + 1G > C, minor allele frequency = 0.56%). This mutation occurs on the HP1 allele of the common copy number variant in HP and leads to a loss of function of HP1. It associates with lower levels of haptoglobin (P = 2.1 × 10-54), higher levels of non-high density lipoprotein cholesterol (ß = 0.26 mmol/l, P = 2.6 × 10-9) and greater risk of coronary artery disease (odds ratio = 1.30, 95% confidence interval 1.10-1.54, P = 0.0024). Through haplotype analysis and with RNA sequencing, we provide evidence of a causal relationship between one of the two haptoglobin isoforms, namely Hp1, and lower levels of non-HDL cholesterol. Furthermore, we show that the HP1 allele associates with various other quantitative biological traits.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Haptoglobinas Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Haptoglobinas Idioma: En Ano de publicação: 2017 Tipo de documento: Article